Latest Breaking News On - Shakil aslam - Page 1 : comparemela.com

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SAN MATEO, Calif., May 20, 2024 /PRNewswire/ Talphera, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically.

Shakil aslamDrug administrationTalphera incPrnewswire talphera incChief development officerNasdaq listing ruleIncentive planBreakthrough device designation

Talphera, Inc (NASDAQ:TLPH) Q1 2024 Earnings Call Transcript

Talphera, Inc (NASDAQ:TLPH) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Raffi asadorianShakil aslamJames molloyVince angottiPam palmerEd arceClinical developmentExchange commissionTeliphone corpAlliance global partnersTalphera incBiocryst pharmaceuticalsGeorgetown universityCall transcript mayTalphera first quarterResults conference

Angion Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney

Angion Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesNational jewish healthJohn neylanShakil aslamJosephv bonventreGregoryp downeyAmerican society of clinical investigationAngion biomedica corpKidney cancer programNational institutes of diabetesHealth sciencesBiomedical researchHarvard medical schoolEarly clinical developmentUniversity of coloradoEngineering in medicine division at brigham

Angion Hosting Research & Development Day on ANG-3070 for

Angion Hosting Research & Development Day on ANG-3070 for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Angion Biomedica : Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney Fibrosis

Angion Biomedica : Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney Fibrosis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNational jewish healthJohn neylanSamuela levineShakil aslamJosephv bonventreGregoryp downeyAmerican society of clinical investigationAngion biomedica corpKidney cancer programNational institutes of diabetesHealth sciencesBiomedical researchGlobenewswire incEngineering in medicine divisionHarvard medical school